Electromed (ELMD) financial statements
Electromed reported revenue of $74M in fiscal 2026, up 12.4% a year over 9 years.
Net income was $11M and the operating margin 18.8%, against 13.8% in 2017.
Free cash flow was $8M, and the company returned $4M in net buybacks.
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Electromed's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26M | $28M | $31M | $32M | $36M | $42M | $48M | $55M | $64M | $74M |
| Cost of revenue | $5M | $7M | $7M | $7M | $8M | $10M | $12M | $13M | $14M | $16M |
| Gross profit | $21M | $22M | $24M | $25M | $27M | $31M | $37M | $42M | $50M | $58M |
| Research and development | $596,876 | $251,443 | $583,311 | $1M | $2M | $1M | $916,000 | $656,000 | $996,000 | $1M |
| Selling, general and admin | $16M | $19M | $20M | $20M | $22M | $27M | $32M | $34M | $39M | $43M |
| Operating income | $4M | $3M | $3M | $5M | $3M | $3M | $4M | $7M | $10M | $14M |
| Pre-tax income | $4M | $3M | $3M | $5M | $3M | $3M | $4M | $7M | $10M | $14M |
| Income tax | $1M | $901,000 | $940,000 | $1M | $805,000 | $692,000 | $920,000 | $2M | $3M | $3M |
| Net income | $2M | $2M | $2M | $4M | $2M | $2M | $3M | $5M | $8M | $11M |
| EPS (diluted) | $0.26 | $0.21 | $0.23 | $0.47 | $0.27 | $0.26 | $0.36 | $0.58 | $0.85 | $1.30 |
| Diluted shares | 8M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| Gross margin | 79.5% | 76.9% | 76.2% | 77.6% | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% | 78.5% |
| Operating margin | 13.8% | 9.6% | 9.0% | 15.8% | 8.8% | 7.1% | 8.3% | 12.0% | 15.1% | 18.8% |
| Net margin | 8.6% | 6.5% | 6.3% | 12.8% | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% | 15.3% |
Balance sheet
Fiscal years, from Electromed's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $6M | $7M | $8M | $10M | $12M | $8M | $7M | $16M | $15M | $20M |
| Receivables | $10M | $12M | $13M | $13M | $17M | $21M | $24M | $23M | $25M | $30M |
| Inventory | $3M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M |
| Total current assets | $18M | $23M | $25M | $28M | $32M | $35M | $38M | $44M | $45M | $57M |
| Property, plant and equipment | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $5M | $5M | $5M |
| Total assets | $23M | $27M | $29M | $33M | $37M | $41M | $46M | $52M | $54M | $66M |
| Total current liabilities | $3M | $5M | $4M | $3M | $5M | $7M | $8M | $8M | $10M | $12M |
| Long-term debt | $1M | — | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $5M | $4M | $3M | $5M | $7M | $8M | $8M | $11M | $12M |
| Shareholders' equity | $20M | $23M | $26M | $30M | $32M | $34M | $38M | $45M | $43M | $54M |
| Net debt | -$4M | -$7M | -$8M | -$10M | -$12M | -$8M | -$7M | -$16M | -$15M | -$20M |
Cash flow
Fiscal years, from Electromed's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1M | $2M | $3M | $4M | $3M | -$686,000 | $1M | $9M | $11M | $10M |
| Capital spending | $618,763 | $526,227 | $1M | $844,000 | $287,000 | $1M | $2M | $287,000 | $262,000 | $1M |
| Free cash flow | $572,358 | $2M | $1M | $3M | $3M | -$2M | -$333,000 | $9M | $11M | $8M |
| Stock-based compensation | $479,482 | $862,674 | $924,071 | $902,000 | $1M | $976,000 | $708,000 | $2M | $3M | $3M |
| Share buybacks (net) | — | — | — | — | -$1M | -$1M | -$153,000 | -$275,000 | -$10M | -$4M |
| Free cash flow margin | 2.2% | 6.8% | 4.0% | 10.3% | 7.8% | -5.1% | -0.7% | 16.0% | 17.4% | 11.4% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ELMD.
Open ELMD in InvestinglyQuestions
What was Electromed's revenue in 2026?
$74M in fiscal 2026, from its 10-K filing.
How much free cash flow does Electromed generate?
$8M in fiscal 2026 (operating cash flow minus capital spending).
From Electromed's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.